Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation‐induced osteoporosis-Reference-Cited by-同舟云学术

Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation‐induced osteoporosis

Published:2017-08-31 Issue:1 Volume:32 Page:52-62
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Chandra Abhishek¹²³,Wang Luqiang¹,Young Tiffany¹,Zhong Leilei¹,Tseng Wei‐Ju¹,Levine Michael A.⁴⁵⁶,Cengel Keith⁷,Liu X. Sherry¹,Zhang Yejia¹⁸⁹,Pignolo Robert J.³,Qin Ling¹

Affiliation:

1. Department of Orthopaedic SurgeryPerelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA

2. Department of Physiology and Biomedical Engineering RochesterMayo Clinic Minnesota USA

3. Department of MedicineMayo Clinic Rochester Minnesota USA

4. Department of PediatricsPerelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA

5. Division of Endocrinology and DiabetesChildren′s Hospital of Philadelphia Philadelphia Pennsylvania USA

6. Center for Bone HealthChildren′s Hospital of Philadelphia Philadelphia Pennsylvania USA

7. Department of Radiation OncologyPerelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA

8. Department of Physical Medicine and RehabilitationPerelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA

9. Translational Musculoskeletal Research Center (TMRC), Corporal Michael J. Crescenz Veterans Affairs Medical Center Philadelphia Pennsylvania USA

Funder

National Institutes of Health

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201700375R

Reference47 articles.

1. Induction of cell death by radiotherapy.

2. Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?

3. Fractures following radiotherapy and limb‐salvage surgery for lower extremity soft‐tissue sarcomas A comparison ofhigh‐dose and low‐dose radiotherapy;Holt G. E.;J. BoneJointSurg. Am,2005

4. Insufficiency fracture after radiation therapy

5. PTH prevents the adverse effects of focal radiation on bone architecture in young rats

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-related disease: Bones;Aging;2024

2. Small-molecule amines: a big role in the regulation of bone homeostasis;Bone Research;2023-07-24

3. Pharmacological options in the treatment of osteogenesis imperfecta: A comprehensive review of clinical and potential alternatives;Biochemical Pharmacology;2023-07

4. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin−/− mice through increasing sclerostin and RANKL/OPG;Bone;2022-11

5. The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity;Frontiers in Endocrinology;2022-09-15